Cargando…
Hyperlipasemia in COVID-19: Statistical Significance vs Clinical Relevance
Autores principales: | Rathi, Sahaj, Sharma, Anand, Patnaik, Itish, Gupta, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721209/ https://www.ncbi.nlm.nih.gov/pubmed/33512808 http://dx.doi.org/10.14309/ctg.0000000000000261 |
Ejemplares similares
-
Hyperlipasemia in Hospitalized COVID-19 Patients
por: Kenner, Maria, et al.
Publicado: (2021) -
COVID-19 Vaccines in Patients With Chronic Liver Disease
por: Sharma, Anand, et al.
Publicado: (2021) -
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020) -
Letter to the editor in response to COVID-19 presenting as acute pancreatitis
por: Gupta, Rohit, et al.
Publicado: (2020) -
Hyperlipasemia Sans Pancreatitis: A Case Series
por: George, Jisa, et al.
Publicado: (2023)